左捆支部节奏改善了末期多变性心肌病的结果:一个案例报告
Manxin Lin1, Shufen Huang1, Xinyi Huang2
1Division of Cardiology, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, Fujian, China.
概括
左捆枝节奏 (LBBP) 为末期多变性心肌病 (HCM) 患者提供了一个有前途的治疗方法,患者的排气分数减少 (EF) 和左捆枝节阻塞 (LBBB). 本案例研究强调了LBBP后的显著恢复,表明其在其他方法失败的情况下的潜在有效性.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏衰竭研究研究
背景情况:
- 超性心肌病 (HCM) 晚期左心室扩大和减少喷射分数 (EF) 表示末期阶段的疾病.
- 在末期的HCM中,完整的左捆分支阻塞 (LBBB) 与预后不佳有关.
- 传统的双心脏节奏在类似的患者队列中显示出有限的益处.
研究的目的:
- 研究左束枝节奏 (LBBP) 作为末期HCM的治疗选择的潜力.
- 报告在患有严重HCM,减少EF和LBBB的患者中成功进行LBBP的病例.
主要方法:
- 一份病例报告,详细介绍了末期多变性心肌病患者的治疗方法.
- 成功植入和利用左束枝节奏 (LBBP).
主要成果:
- 患有终末期高伤心肌病的患者在LBBP后经历了显著的康复.
- 左捆支部节奏 (LBBP) 在双心脏节奏影响有限的情况下表现出显著的积极效果.
结论:
- 左束枝节奏 (LBBP) 可能是一个可行的和有效的策略,用于管理末期高伤心肌病 (HCM) 与左心室功能障碍和LBBB.
- 这一案例凸显了LBBP在逆转不良改造和改善复杂心脏病的结果方面的潜力.
相关概念视频
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


